Jennifer Markarian

Collecting and analyzing data are crucial for creating efficient, automated bioprocesses.

Filling and packaging of primary containers is a crucial piece of COVID-19 vaccine production.

Automated sampling systems and integration of PAT are overcoming some of the roadblocks to increased automation of biopharmaceutical manufacturing processes.

Pumps and other components meet the demands of single-use systems in biopharmaceutical downstream processing.

Higher cell densities are driving innovations in harvesting, including closed systems for intensified processes.

Suppliers address the complexity of supplying disposable components for single-use systems to the global biopharmaceutical manufacturing industry.

Single-use components for biopharmaceutical manufacturing have a lower environmental impact than reusable components, but disposal is still a consideration.

Modern technologies, including Industry 4.0 and the Industrial Internet of Things, offer opportunities to increase biopharmaceutical manufacturing efficiency.

Silicone is one of the polymeric materials that can be used for single-use components and assemblies in biopharmaceutical manufacturing.

BioPharm International asked Andrew Bulpin, head of Process Solutions at MilliporeSigma, about the end-of-life options for disposable components of biopharmaceutical single-use systems.